Lv1
40 积分 2024-04-19 加入
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma
7天前
已完结
Exploring the therapeutic potential of monoclonal antibodies targeting TSLP and IgE in asthma management
10天前
已完结
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
23天前
已完结
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
23天前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
24天前
已完结
Translational Investigation of CM326 from Preclinical Studies to Randomized Phase I Clinical Trials in Healthy Adults
25天前
已完结
Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
1个月前
已完结
A role for TSLP in the development of inflammation in an asthma model
1个月前
已完结
Exploring the therapeutic potential of monoclonal antibodies targeting TSLP and IgE in asthma management
1个月前
已完结
Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies
1个月前
已完结
皖公网安备34019202002308
